HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,321-1,332 of 1,979
Drug study icon
CompletedEUCTR 2017-000918-36

A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolarity type I

Official study title

A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
Bipolarity, SchizophreniaHistorical research record
Countries
Austria, Bulgaria, Ireland, + 3 others
Sponsor
Alkermes Inc
Drug study icon
CompletedEUCTR 2017-003112-39

A Randomised Double-Blinded Placebo-Controlled Trial to Assess the Efficacy and Safety of Scopolamine Compared to Placebo in Individuals with Bipolarity who are Experiencing a Depressive Epis...

Official study title

A Randomised Double-Blinded Placebo-Controlled Trial to Assess the Efficacy and Safety of Scopolamine Compared to Placebo in Individuals with Bipolar Disorder who are Experiencing a Depressive Epis...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Ireland
Bipolarity, DepressionHistorical research record
Countries
Ireland
Sponsor
National University of ireland Galway
Drug study icon
CompletedEUCTR 2008-007457-13

A Randomized, 6-Week, Double-Blind, Placebo-controlled, Fixed-Flexible-Dose, Parallel-Group Study of Lurasidone in the Treatment of Bipolar I Depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
Bipolarity, DepressionHistorical research record
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Drug study icon
CompletedEUCTR 2008-007482-23

A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
Bipolarity, DepressionHistorical research record
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Drug study icon
CompletedEUCTR 2010-019778-34

A RANDOMIZED, 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLEXIBLE-DOSE, PARALLEL-GROUP STUDY OF LURASIDONE ADJUNCTIVE TO LITHIUM OR DIVALPROEX FOR THE TREATMENT OF BIPOLAR I DEPRESSION IN SUBJECTS ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
Bipolarity, DepressionHistorical research record
Countries
Czechia, Lithuania, Slovakia
Sponsor
Sunovion, Inc.
Drug study icon
CompletedEUCTR 2018-000103-16

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SEP-4199 for the Treatment of Major Depressive Episode Associated with Bipolarity type I

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SEP-4199 for the Treatment of Major Depressive Episode Associated with Bipolar I Disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Depression, BipolarityHistorical research record
Countries
Bulgaria, Poland, Slovakia
Sponsor
SUNOVION PHARMACEUTICALS INC.
Drug study icon
CompletedEUCTR 2011-000986-10

A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, FLEXIBLE-DOSE, PARALLEL-GROUP STUDY OF LURASIDONE ADJUNCTIVE TO LITHIUM OR DIVALPROEX FOR THE PREVENTION OF RECURRENCE IN SUBJECTS WITH BIPOLAR I DISO...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
Bipolarity, DepressionHistorical research record
Countries
Czechia, Hungary, Poland, + 1 other
Sponsor
Sunovion Pharmaceuticals Inc.
Drug study icon
TerminatedEUCTR 2006-001317-15

BALANCE 2: Bipolarity:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation

Official study title

BALANCE 2: Bipolar disorder:Antidepressant/Lamotrigine/ANtipsychotic Comparative Evaluation

Original registry wording; source language not specified.

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
Bipolarity, DepressionHistorical research record
Countries
United Kingdom
Sponsor
University of Oxford (University)
Drug study icon
CompletedEUCTR 2007-004513-33

Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In United Kingdom
Bipolarity, DepressionHistorical research record
Countries
United Kingdom
Sponsor
University of Oxford (University)
Biological study icon
CompletedEUCTR 2016-004023-24

Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with Bipolarity and unipolar depression in remission (PRETEC-EPO)

Official study title

Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with bipolar disorder and unipolar depression in remission (PRETEC-EPO)

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark
Bipolarity, DepressionHistorical research record
Countries
Denmark
Sponsor
Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.